Enfuvirtide FDA Link

A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS.

Also Known As:

Fuzeon; DP 178; DP-178; DP178; Pentafuside; Peptide T20; T20 Peptide; T20, Peptide

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Membrane Fusion Proteins: 5
      - Viral Fusion Proteins: 34
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 194
  - Viral Proteins: 4250
    - Viral Antigens: 3254
      - HIV Antigens: 144
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 194
    - Viral Structural Proteins: 171
      - Viral Envelope Proteins: 291
        env Gene Products: 219
        Human Immunodeficiency Virus env Gene Products
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 194
        Viral Fusion Proteins: 34
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 194
    - Retroviridae Proteins: 7
      - env Gene Products: 219
        Human Immunodeficiency Virus env Gene Products
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 194
      - Human Immunodeficiency Virus Proteins: 143
        Human Immunodeficiency Virus env Gene Products
        HIV Envelope Protein gp41: 6
        Enfuvirtide: 194
- Peptides: 82426
  - Peptide Fragments: 373
    - Enfuvirtide: 194
Biological Factors: 2472
- Antigens: 143924
  - Viral Antigens: 3254
    - HIV Antigens: 144
      - HIV Envelope Protein gp41: 6
        Enfuvirtide: 194

Create Custom RSS News Feed:
	Enfuvirtide (Fuzeon)
	Ibandronic Acid (Boniva)
	Mycophenolic Acid (Cellcept)

Roche Diagnostics Gmbh Product Research

Products